Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Two prospective dosing methods for nortriptyline.

P J Perry, J L Browne, B Alexander

    Clinical Pharmacokinetics
    |November 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    O blood usage trends in the pediatric population 2015-2019: A multi-institutional analysis.

    Transfusion·2025
    Same author

    Olfaction in the Anthropocene: NO<sub>3</sub> negatively affects floral scent and nocturnal pollination.

    Science (New York, N.Y.)·2024
    Same author

    Constructing evidence-based clinical intrapartum care algorithms for decision-support tools.

    BJOG : an international journal of obstetrics and gynaecology·2022
    Same author

    Abyssal Benthic Rover, an autonomous vehicle for long-term monitoring of deep-ocean processes.

    Science robotics·2021
    Same author

    Longitudinal Flow Decorrelations in Xe+Xe Collisions at sqrt[s_{NN}]=5.44  TeV with the ATLAS Detector.

    Physical review letters·2021
    Same author

    Search for Dark Matter Produced in Association with a Dark Higgs Boson Decaying into W^{±}W^{∓} or ZZ in Fully Hadronic Final States from sqrt[s]=13  TeV pp Collisions Recorded with the ATLAS Detector.

    Physical review letters·2021
    Same journal

    Population Pharmacokinetic Modelling of Dolutegravir: A Narrative Review.

    Clinical pharmacokinetics·2026
    Same journal

    Partial Area Under the Curve: A Revelatory Story in Pharmacokinetics.

    Clinical pharmacokinetics·2026
    Same journal

    Informing Sampling Design for Lung Distribution Studies Using a Pulmonary Population Minimal PBPK Model.

    Clinical pharmacokinetics·2026
    Same journal

    Revisited Pharmacokinetic Profiles of Methylprednisolone in Plasma and Urine After Single and Multiple Oral Administrations: Relevance in Sports Drug Testing.

    Clinical pharmacokinetics·2026
    Same journal

    ALBI Grade is a Determinant of Lenvatinib Pharmacokinetics, Efficacy, and Toxicities in Japanese Patients with Hepatocellular Carcinoma.

    Clinical pharmacokinetics·2026
    Same journal

    Quantitative Pharmacology Justifying Ribociclib Dose in Early Breast Cancer.

    Clinical pharmacokinetics·2026
    See all related articles

    Predicting nortriptyline steady-state concentrations can be done using a single blood draw at 36 hours, similar to methods requiring multiple draws. This simplifies therapeutic drug monitoring for nortriptyline.

    Area of Science:

    • Pharmacokinetics
    • Clinical Pharmacology
    • Therapeutic Drug Monitoring

    Background:

    • Accurate prediction of drug steady-state concentrations is crucial for effective therapeutic drug monitoring.
    • Nortriptyline, a tricyclic antidepressant, requires careful dosing to optimize efficacy and minimize toxicity.
    • Existing pharmacokinetic dosing methods for nortriptyline vary in complexity and required sampling points.

    Purpose of the Study:

    • To compare the accuracy of two prospective pharmacokinetic dosing methods for predicting nortriptyline steady-state concentrations.
    • To evaluate a single-point prediction method using a 36-hour plasma concentration against a multiple-point method.
    • To assess the clinical utility of these dosing protocols.

    Main Methods:

    • Prospective pharmacokinetic dosing was employed.

    Related Experiment Videos

  • One method involved multiple plasma concentration measurements.
  • The second method utilized a single plasma concentration measurement at 36 hours post-dose (NTP 36h) substituted into a linear equation (Cssav = 17.2 + 3.74 (NTP 36h)).

    • Main Results:

    • No significant differences were observed between observed steady-state concentrations (121 +/- 19 ng/ml) and predicted concentrations from both the single-point (121 +/- 21 ng/ml) and multiple-point (122 +/- 19 ng/ml) methods.
    • The 36-hour single-point prediction accurately reflected the average steady-state concentration for a 100 mg/day nortriptyline dose.

    Conclusions:

    • A single plasma concentration measurement at 36 hours is a reliable method for predicting nortriptyline steady-state concentrations.
    • This single-point method offers a potentially simpler alternative to multiple-point methods for pharmacokinetic dosing of nortriptyline.
    • The study discusses the clinical advantages and disadvantages of each prospective dosing protocol.